Neither marijuana nor nicotine is categorically “worse” across every measure of harm. Nicotine is substantially more addictive, and tobacco use accounts for a far larger share of global death and disability. But marijuana carries its own distinct risks, particularly to mental health, that nicotine does not. The honest comparison depends on which organ system, which population, and which pattern of use you’re looking at. The two substances damage the body through different mechanisms, on different timelines, and the picture gets more complicated when people use both at once.
Which One Is More Addictive
On pure addictiveness, nicotine wins by a wide margin. A large U.S. population study found that nicotine was the most addictive of four major substances examined, ahead of alcohol, marijuana, and cocaine.1PubMed. Prevalence and demographic correlates of symptoms of last year dependence on alcohol, nicotine, marijuana and cocaine in the U.S. population Roughly a quarter to a third of people who try cigarettes develop dependence, while the figure for marijuana is closer to one in ten. Nicotine hooks users faster, too: many smokers report feeling dependent within weeks of their first cigarettes, while cannabis dependence tends to build more gradually over months or years of regular use.
That said, the gap may be narrower than people assume when it comes to the experience of quitting. A study comparing real-world cannabis and tobacco users found that overall withdrawal discomfort scores were virtually identical between the two groups. Craving and sweating were slightly worse for tobacco quitters, but both groups said withdrawal contributed heavily to relapse.2PubMed Central. Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse So while fewer marijuana users become dependent in the first place, those who do can find quitting just as miserable as giving up cigarettes.
Brain imaging adds some nuance here. Cannabis users show blunted reward-system activity in the caudate nucleus compared to both non-users and tobacco smokers, suggesting that the two substances alter the brain’s reward circuitry through partially overlapping but distinct pathways.3PubMed. Chronic effects of cannabis use on the human reward system: an fMRI study Those differences matter because they mean treating cannabis dependence is not simply a milder version of treating nicotine dependence; the neurological targets are not identical.
What Each One Does to Your Lungs
Smoking anything is bad for your lungs, but the way people smoke marijuana makes each joint deliver a heavier respiratory hit than a single cigarette. A landmark study in the New England Journal of Medicine found that compared to tobacco, smoking marijuana produced roughly five times more carbon monoxide in the blood, about three times more inhaled tar, and a third more tar retained in the airways. Marijuana smokers took larger puffs, inhaled more deeply, and held their breath about four times longer.4PubMed. Pulmonary hazards of smoking marijuana as compared with tobacco Puff for puff, marijuana smoke puts more combustion byproducts into your respiratory tract.
Chemical analysis of the smoke itself tells a similar story: marijuana smoke contains ammonia at concentrations up to 20 times higher than tobacco smoke, and hydrogen cyanide and nitrogen oxides at three to five times higher levels.5Chemical Research in Toxicology. A Comparison of Mainstream and Sidestream Marijuana and Tobacco Cigarette Smoke Produced under Two Machine Smoking Conditions Cannabis smoke also contains many of the same carcinogenic chemicals found in tobacco smoke and is typically inhaled more deeply.6PubMed. Cannabis smoking and respiratory health: consideration of the literature
Yet here is where the comparison gets surprising. Despite all those nasty chemicals per puff, the evidence linking cannabis smoke to lung cancer is far weaker than for tobacco. A review examining the biological consequences of inhaling both types of smoke found reasons to believe that tobacco smoke, but not cannabis smoke, leads to lung cancer.7PubMed Central. Cannabis and tobacco smoke are not equally carcinogenic The likely explanation involves dose and frequency: a heavy cigarette smoker may inhale 20 or more times a day, every day, for decades, while even a daily marijuana user typically smokes far less total material. Cannabinoids themselves may also have anti-tumor properties that partially offset the carcinogenic load, though this is still an area of active debate. The respiratory picture, then, is a study in contrasts: marijuana delivers more toxins per session, but tobacco’s relentless daily volume makes it the far bigger lung cancer threat in practice.
Cardiovascular Risks Run on Different Timelines
Nicotine’s damage to the heart and blood vessels is chronic, cumulative, and well documented. It damages the inner lining of blood vessels, promotes the buildup of arterial plaque, and drives structural remodeling of the heart over time.8PubMed Central. Nicotine induces endothelial dysfunction and promotes atherosclerosis via GTPCH1 These effects aren’t limited to cigarette smokers; nicotine alters blood vessel function in e-cigarette users as well, through both direct effects on the vessel lining and changes to the smooth muscle underneath it.9PubMed Central. Nicotine and vascular dysfunction Over years, this process contributes to hypertension, atherosclerosis, arrhythmias, and heart failure.10PubMed. Nicotine-associated cardiovascular dysfunction: From pharmacological insights to emerging therapeutic interventions
Marijuana’s cardiovascular threat is different: more acute and more event-driven. THC can reduce coronary blood flow through vasospasm while simultaneously increasing heart rate and blood pressure, creating a supply-demand mismatch for oxygen in the heart muscle. Imaging of patients who had heart attacks associated with THC use typically finds no underlying plaque disease at all; instead, the problem is coronary spasm and clot formation in otherwise healthy arteries.11PubMed Central. Cannabis and Myocardial Infarction: Risk Factors and Pathogenetic Insights People with preexisting heart conditions like stable angina are especially vulnerable. Studies have found that THC use decreases the amount of exercise time before angina symptoms appear.
In short, nicotine slowly builds the conditions for a heart attack over decades by promoting plaque and stiffening arteries. THC can trigger one in a single session by squeezing already-narrow arteries and spiking demand for oxygen. If you have a healthy cardiovascular system, the long-term threat from chronic nicotine is much larger. If you already have heart disease, even occasional marijuana use introduces an acute risk that nicotine alone may not.
Mental Health Is Where Marijuana Pulls Ahead in Risk
This is the domain where cannabis clearly poses the greater danger, particularly for younger users. A large study published in JAMA Health Forum found that past-year cannabis use among adolescents was associated with roughly double the risk of developing a psychotic disorder and a doubled risk of bipolar disorder, along with smaller but still meaningful increases in depressive and anxiety disorders.12JAMA Health Forum. Adolescent Cannabis Use and Risk of Psychotic, Bipolar, Depressive, and Anxiety Disorders Nicotine is associated with anxiety and mood problems, but its connection to psychosis is far weaker.
Research on people already at clinical high risk for psychosis sharpens the picture further. More frequent cannabis use at baseline was associated with higher risk of converting to a full psychotic disorder. Heavy cannabis combined with even light tobacco use roughly tripled that conversion risk compared to using neither substance.13Nature Mental Health. Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts Heavy co-use of both substances together pushed the risk even higher.14PubMed Central. Cannabis and tobacco co-use predicts psychosis in clinical high risk cohorts
Tobacco use in these studies was also linked to greater psychiatric symptom severity across most domains, but the standout finding was cannabis’s unique relationship with psychosis. Nicotine doesn’t appear to trigger psychotic breaks on its own in the way that high-dose THC can. For anyone with a personal or family history of psychotic illness, this is probably the single most important difference between the two substances.
Adolescent Brain Development
Both substances are bad news for the developing brain, and the harms are more similar than you might expect. A review examining how nicotine and cannabis affect adolescent neurodevelopment concluded that their overall impact on the teenage brain is “remarkably similar,” even though they work through different neural circuits.15Berkeley Pharma Tech Journal of Medicine. Addiction Risk, Decision Making, and Mood Regulation: The Impact of Nicotine and Cannabis on Adolescent Brain Development Both disrupt decision-making, mood regulation, and the brain’s reward pathways during a period when those systems are still being wired.
The practical takeaway is that the “which one is safer for teens” framing is the wrong question. Neither is safe for a brain that won’t finish maturing until the mid-twenties. The fact that the two substances act through different mechanisms means that co-use, which is common among adolescents, may compound the damage in ways that neither would cause alone. Brain imaging research supports this: combined cannabis and nicotine use shows distinct patterns of disruption to resting-state brain networks that differ from those seen with either substance in isolation.16PubMed Central. Differential associations of combined vs. isolated cannabis and nicotine on brain resting state networks
Pregnancy Risks From Either Substance
Prenatal exposure to either nicotine or cannabis increases the risk of adverse outcomes for the baby, and the two substances cause strikingly similar rates of problems when used alone. In a study of over three million pregnancies, cannabis-only and nicotine-only diagnoses were each associated with comparable rates of infant death, small-for-gestational-age births, and preterm delivery. But combined use was worse than either alone: the rate of infant death roughly doubled, and preterm delivery climbed to about one in six pregnancies.17JAMA Network Open. Risk of Adverse Neonatal Outcomes After Combined Prenatal Cannabis and Nicotine Exposure
Animal models confirm that both substances independently harm placental function, fetal growth, and offspring neurodevelopment.18PubMed Central. Animal Models Evaluating the Impact of Prenatal Exposure to Tobacco and Marijuana In human data, children exposed in utero to either substance had slightly lower median IQ scores than unexposed children, though the differences were modest and not always statistically significant. One notable finding was that children exposed prenatally to THC scored higher on attention-problem measures at age four compared to unexposed children.19PubMed Central. Prenatal Nicotine or Cannabis Exposure and Offspring Neurobehavioral Outcomes The perception that marijuana is “natural” and therefore safer during pregnancy is not supported by the available evidence.
The Population-Level Scoreboard
When you zoom out from individual risk to the population level, the comparison isn’t close. Tobacco is one of the leading causes of preventable death worldwide. A global burden of disease analysis found that tobacco accounted for about 4% of global disability-adjusted life years, placing it among the top risk factors for disease in developed countries with the highest mortality risk of any substance.20PubMed. Global burden of disease from alcohol, illicit drugs and tobacco Cannabis dependence, by contrast, accounted for roughly 0.08% of global disability-adjusted life years. Cannabis was the only substance category for which there were zero attributable deaths in the global burden of disease calculations.21PLOS ONE. The Global Epidemiology and Contribution of Cannabis Use and Dependence to the Global Burden of Disease: Results from the GBD 2010 Study
This enormous gap reflects several realities. Tobacco users smoke far more frequently and over longer periods. Nicotine’s addictiveness keeps people locked in. And the diseases tobacco causes, particularly lung cancer and cardiovascular disease, are among the deadliest conditions in medicine. Marijuana can ruin lives through dependence, psychiatric illness, and impaired functioning, but it does not produce the massive body count that tobacco does. That distinction matters enormously for public health policy, even though it shouldn’t be taken as a green light for heavy cannabis use.
Why Co-Use Makes Everything Worse
A large and growing number of people use both substances, often in the same session. Blunts (cannabis rolled in tobacco leaf) and spliffs (cannabis mixed with loose tobacco) are common in many regions, and vaping devices can be loaded with either or both. This matters because co-use doesn’t just add the risks together; it appears to multiply certain harms. A systematic review found that co-occurring cannabis and tobacco use was associated with a greater likelihood of developing a cannabis use disorder, more psychosocial problems, and worse outcomes when trying to quit cannabis.22PubMed Central. Clinical Correlates of Co-Occurring Cannabis and Tobacco Use: A Systematic Review
The biology behind this interaction is becoming clearer. Preclinical evidence suggests that prior THC exposure can enhance the rewarding effects of nicotine, potentially increasing dependence severity. Quitting one substance can intensify withdrawal from the other, creating a feedback loop in which every cessation attempt is undermined by the drug you’re still using. Conditioned associations between the two, especially when consumed together in the same product, can trigger relapse to either one.23medRxiv. Cannabis Co-Use and Endocannabinoid System Modulation in Tobacco Use Disorder: A Translational Systematic Review and Meta-Analysis Clinicians increasingly recognize that treating one addiction while ignoring the other is a recipe for failure.
How Vaping Changes the Equation
Many people assume that vaping is vaping, regardless of what’s in the cartridge. It isn’t. A study comparing the pulmonary effects of vaping cannabidiol (CBD) aerosol versus nicotine aerosol found that CBD vaping caused greater inflammatory changes, more severe lung damage, and higher oxidative stress than nicotine vaping. CBD aerosol also showed higher toxicity to human cells.24PubMed. Not all vaping is the same: differential pulmonary effects of vaping cannabidiol versus nicotine This was a controlled laboratory study, not a long-term epidemiological finding, but it challenges the assumption that cannabis vaping is the gentler option for your lungs.
Delivery method also affects how quickly a substance hits and how much of it your body absorbs. Inhaled THC reaches peak blood levels within about six to ten minutes, with a bioavailability of roughly 10 to 35 percent. Edible THC, by contrast, has a bioavailability of only about 4 to 12 percent and takes much longer to kick in.25PubMed Central. Mechanisms of Action and Pharmacokinetics of Cannabis That slow onset with edibles is precisely why accidental overconsumption is so common: people eat more because they don’t feel anything yet, then absorb a much larger dose than intended. Nicotine products have a similar range of delivery speeds, from rapid-acting cigarettes and vapes to slower-release patches and gums.
Immune System Effects
The two substances push the immune system in somewhat different directions. Nicotine has been found to be generally pro-inflammatory with respect to cytokines, the signaling molecules that coordinate immune responses. THC and CBD, on the other hand, have been associated with conflicting effects, sometimes amplifying and sometimes dampening inflammation depending on the context.26PubMed. The Effects of Nicotine and Cannabinoids on Cytokines This dual nature is part of why cannabinoids have been investigated as potential treatments for autoimmune and inflammatory conditions, while nicotine has not.
For a healthy person, the practical significance of these immune effects is modest. For someone with a chronic inflammatory condition like rheumatoid arthritis or Crohn’s disease, cannabis’s immunomodulatory properties might theoretically be relevant, though clinical evidence for therapeutic use remains mixed. Nicotine’s consistently pro-inflammatory tendency, by contrast, contributes to the systemic vascular damage discussed earlier and offers no corresponding therapeutic upside.
Contaminants and Product Safety
One risk factor that gets overlooked in the marijuana-versus-nicotine debate is what else comes along with the product. Commercial tobacco is tightly regulated in most countries, and while cigarettes contain thousands of chemicals, those chemicals are at least consistent from pack to pack. Cannabis products, depending on where you live, may not have the same oversight. Common contaminants in cannabis include microbes, heavy metals, and pesticides, and their direct toxicity to humans is still poorly studied.27PubMed Central. Cannabis contaminants: sources, distribution, human toxicity and pharmacologic effects In jurisdictions with legal, regulated cannabis markets, testing requirements have reduced these risks. In unregulated markets, including most of the world, you may be inhaling lead, mold, or banned pesticides alongside your THC.
This is a dimension of risk where legality and regulation matter as much as pharmacology. A cannabis user buying from a tested dispensary in a legal state faces a very different contaminant profile than someone buying from an unregulated source. Nicotine users face their own contaminant concerns with illicit or counterfeit vape cartridges, as the EVALI outbreak of 2019 demonstrated, but the baseline product from a licensed manufacturer is at least predictable. For a fair comparison, you have to consider not just what each substance does to the body, but what else might be riding along with it.